Bipolar disorder trials in Israel

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  Where

  Beersheba, Hod HaSharon, Jerusalem, Ness Ziona, Petah Tikva, Ramat Gan

  Age

  18 years to 65 years

  People

  274 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06951711
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  Where

  Ashkelon, Beersheba, Hod HaSharon, Jerusalem, Ramat Gan

  Age

  18 years to 65 years

  People

  424 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07140913
• Phase 3Taking people
  A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  Where

  Ashkelon, Beersheba, Hod HaSharon, Jerusalem, Ness Ziona, Petah Tikva, Ramat Gan

  Age

  18 years to 65 years

  People

  450 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06929273 · EU 2024-520259-26-00
• Phase 1/2Taking people
  Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

  Where

  Beersheba, Ness Ziona, Ramat Gan, Tel Aviv

  Age

  18 years to 64 years

  People

  24 worldwide

  Run by

  Mapi Pharma Ltd.

  See details and how to joinNCT07185815